Constellation Pharmaceuticals, Inc.
Records under this name other than the patents Constellation Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 42 patents it holds.
Back to Constellation Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,358,437 | Therapeutic Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,206,931 | Therapeutic Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,763,922 | Therapeutic Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,280,149 | Therapeutic Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,301,253 | Therapeutic Compounds and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,414,384 | P300/CBP Hat Inhibitors Lapsed on the fee record Ended Aug 16, 2026 · High confidence | Lapsed on the fee record | Ended Aug 16, 2026 | High confidence |
| US 10,035,801 | Pyrazolo Compounds and Uses Thereof Lapsed on the fee record Ended Jul 31, 2026 · High confidence | Lapsed on the fee record | Ended Jul 31, 2026 | High confidence |
| US 10,022,354 | Pyrrolidine Amide Compounds as Histone Demethylase Inhibitors Formerly held Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 10,016,405 | Modulators of Methyl Modifying Enzymes, Compositions and Uses Thereof Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |
| US 9,980,952 | Modulators of methyl modifying enzymes, compositions and uses thereof Lapsed on the fee record Ended May 29, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2026 | From the USPTO record |